Yu-Ping Wang
Cardiovascular Disease · Stanford, CANPI 1275717761
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $59,953 of the $79,127 with a category attached, or 75.8%. 9 manufacturers reported payments, led by AstraZeneca at 26.7% of the total. Reporting peaked in 2021 at $29,720 and has fallen 99.7% since, to $77 in 2025. Among cardiovascular disease clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 62 payments — averaging $1276.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$21K
- Artivion, Inc.$20K
- Novartis$18K
- CSL Behring$10K
- E.r. Squibb & Sons, L.L.C.$5K
- Bio Products Laboratory USA, Inc.$3K
- plus $2K from 3 others
Across 24 payments — averaging $154,281 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Artivion, Inc.$3.2M
- AstraZeneca$295K
- Regeneron$162K
- Boston Scientific$44K
- Novo Nordisk AS$11K
What the payments were for
- Consulting fees$59,95376%
- Speaking & faculty fees$14,44118%
- Travel & lodging$3,4944%
- Food & beverage$1,1441%
- Education$950%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 20 | $21,162 |
| Artivion, Inc. | 18 | $19,621 |
| Novartis | 7 | $17,717 |
| CSL Behring | 3 | $10,435 |
| E.r. Squibb & Sons, L.L.C. | 4 | $5,273 |
| Bio Products Laboratory USA, Inc. | 2 | $2,750 |
| Regeneron | 3 | $1,878 |
| Johnson & Johnson(2 entities) | 2 | $214 |
| LEO Pharma Inc. | 3 | $77 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LEQVIO$10,357
- ON-X AORTIC HEART VALVE WITH CONFORM-X SEWING RING AND EXTENDED HOLDER$9,969
- On-X$8,828
- BRILINTA$4,833
- CRESTOR$4,028
- ELIQUIS$3,250
- Gammaplex$2,750
- PRALUENT$1,785
- CRYOVALVE SG PULMONARY HUMAN HEART VALVE$700
- XARELTO$119
How this compares
$79,127 in reported general payments places this provider in the 95th percentile of 2,184 cardiovascular disease providers in California.
Other cardiovascular disease in Stanford
- Wilber SuStanford$1.1M
- Euan AshleyStanford$508K
- Kenneth MahaffeyStanford$447K
- Ted LoveHillsborough$102.8M
- Paul KurthSanta Barbara$6.1M
- Jason RogersSacramento$4.4M
- Matthew BudoffTorrance$3.6M
- Eric Topolla Jolla$2.2M
- Cathleen Bairey-MerzLos Angeles$1.2M
- Gagan SinghSacramento$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.